Clinical trial
Radiation Therapy in Treating Patients With Aggressive Fibromatoses
NCT00030680 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00030680 |
|---|---|
| Title | Radiation Therapy in Treating Patients With Aggressive Fibromatoses |
| Official title | Phase II Pilot Study Of Moderate Dose Radiotherapy For Inoperable Aggressive Fibromatoses |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Desmoid Tumor |
| Intervention type | Radiation |
| Interventions | radiation therapy |
| Enrollment | 44 |
| Start date | Nov 1, 2001 |
| Primary completion | Mar 1, 2012 |
| Completion | Mar 1, 2012 |
| First posted | Jan 27, 2003 |
| Last update posted | Aug 27, 2013 |
| Countries | Belgium, France, Germany, Netherlands, Poland, Switzerland, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: